Understanding how the body's internal clock affects insulin-producing cells in the pancreas.
Circadian Control of Pancreatic Beta-cell Maturation
['FUNDING_CAREER'] · UNIVERSITY OF PENNSYLVANIA · NIH-10888097
This study is looking at how a special protein helps insulin-producing cells in the pancreas grow and work better, which could lead to new ways to help people with diabetes manage their blood sugar levels.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10888097 on ClinicalTrials.gov |
What this research studies
This research investigates how pancreatic beta cells, which produce insulin, mature and respond to glucose levels in the body. It focuses on the role of a specific protein, Dec1, that is activated during the maturation of these cells and how it influences their ability to secrete insulin. By studying the molecular mechanisms behind this process, the research aims to uncover ways to improve beta cell function, which is crucial for managing diabetes. The approach includes examining changes at the genetic and protein levels in beta cells to understand their development better.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for type 1 or type 2 diabetes, particularly those with early signs of beta cell dysfunction.
Not a fit: Patients who are not at risk for diabetes or have advanced diabetes with significant beta cell loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diabetes by enhancing the function of insulin-producing cells.
How similar studies have performed: Previous research has shown promising results in understanding beta cell maturation and its implications for diabetes treatment, indicating that this approach has potential for success.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALVAREZ, JUAN R — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: ALVAREZ, JUAN R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.